1
|
López-González Á, García-Quintanilla M, Guerrero-Agenjo CM, Tendero JL, Guisado-Requena IM, Rabanales-Sotos J. Eficacy of Cryotherapy in the Prevention of Oral Mucosistis in Adult Patients with Chemotherapy. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021; 18:ijerph18030994. [PMID: 33498628 PMCID: PMC7908620 DOI: 10.3390/ijerph18030994] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/24/2020] [Revised: 01/14/2021] [Accepted: 01/19/2021] [Indexed: 12/22/2022]
Abstract
Oral mucositis (OM) is a common side effect of cancer therapies. It causes ulcerative, painful lesions in the oral cavity that can provoke malnutrition, increased risk of infection, longer hospital stays, and seriously affect the quality of life. Cooling the mucosa with oral cryotherapy (OC) during and/or after chemotherapy is the most accessible and tolerable intervention available. The aim of this study is to define the efficacy of OC for preventing OM induced by chemotherapy/radiotherapy in adult patients with cancer. Secondary endpoints include associated problems as pain. A systematic search was performed using the Pubmed, WOS (Web of Science), Cochrane Library, CINAHL, and BVS databases for articles published up to 2010. After inclusion and exclusion criteria were applied, a total of eight articles were analyzed in this review. In seven of the eight articles, the incidence of OM of all grades was significantly lower in the OC group compared with the no-OC group. Use of opioids and level of pain were also significantly reduced. OC is an effective intervention to reduce the incidence of OM induced by chemotherapy as well as the associated severity and pain. Based on these results, OC with only water or with chamomile, associated or not with other mouthwash therapies, is an effective intervention to reduce the incidence of OM induced by chemotherapy as well as the associated severity and pain.
Collapse
Affiliation(s)
- Ángel López-González
- Department of Nursing, Physiotherapy and Occupational Therapy, Facultad de Enfermería, Universidad de Castilla-La Mancha, Campus Univesitario s/n, 02071 Albacete, Spain; (Á.L.-G.); (M.G.-Q.); (J.R.-S.)
- Group of Preventive Activities in the University Health Sciences Setting, Universidad de Castilla-La Mancha/UCLM, 13001 Ciudad Real, Spain
| | - Marta García-Quintanilla
- Department of Nursing, Physiotherapy and Occupational Therapy, Facultad de Enfermería, Universidad de Castilla-La Mancha, Campus Univesitario s/n, 02071 Albacete, Spain; (Á.L.-G.); (M.G.-Q.); (J.R.-S.)
| | - Carmen María Guerrero-Agenjo
- Castilla-La Mancha Health Service (Servicio de Salud de Castilla-La Mancha/SESCAM), Universidad de Castilla-La Mancha/UCLM, 02071 Albacete, Spain; (C.M.G.-A.); (J.L.T.)
| | - Jaime López Tendero
- Castilla-La Mancha Health Service (Servicio de Salud de Castilla-La Mancha/SESCAM), Universidad de Castilla-La Mancha/UCLM, 02071 Albacete, Spain; (C.M.G.-A.); (J.L.T.)
| | - Isabel María Guisado-Requena
- Department of Nursing, Physiotherapy and Occupational Therapy, Facultad de Enfermería, Universidad de Castilla-La Mancha, Campus Univesitario s/n, 02071 Albacete, Spain; (Á.L.-G.); (M.G.-Q.); (J.R.-S.)
- Group of Preventive Activities in the University Health Sciences Setting, Universidad de Castilla-La Mancha/UCLM, 13001 Ciudad Real, Spain
- Correspondence: ; Tel.: +34-967-599-200 (ext. 2735)
| | - Joseba Rabanales-Sotos
- Department of Nursing, Physiotherapy and Occupational Therapy, Facultad de Enfermería, Universidad de Castilla-La Mancha, Campus Univesitario s/n, 02071 Albacete, Spain; (Á.L.-G.); (M.G.-Q.); (J.R.-S.)
- Group of Preventive Activities in the University Health Sciences Setting, Universidad de Castilla-La Mancha/UCLM, 13001 Ciudad Real, Spain
| |
Collapse
|
2
|
Kim SY, Son HM. The Effects of Oral Cryotherapy on Nausea, Vomiting, Oral Mucositis, and Oral Pain in Breast Cancer Patients Undergoing Chemotherapy. ASIAN ONCOLOGY NURSING 2020. [DOI: 10.5388/aon.2020.20.3.132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Affiliation(s)
| | - Haeng-Mi Son
- Department of Nursing, University of Ulsan, Ulsan, Korea
| |
Collapse
|
3
|
Ruddy KJ, Le-Rademacher J, Lacouture ME, Wilkinson M, Onitilo AA, Vander Woude AC, Grosse-Perdekamp MT, Dockter T, Tan AD, Beutler A, Loprinzi CL. Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I); an ACCRU trial. Breast 2019; 48:89-97. [PMID: 31590108 DOI: 10.1016/j.breast.2019.09.011] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2019] [Revised: 09/17/2019] [Accepted: 09/18/2019] [Indexed: 02/08/2023] Open
Abstract
PURPOSE This pilot trial aimed to assess if cooling hands and feet with crushed ice during receipt of paclitaxel helps prevent peripheral neuropathy. METHODS This prospective, randomized trial compared cryotherapy to standard care in patients initiating paclitaxel weekly x 12. For those on cryotherapy, hands and feet were cooled starting 15 min prior to and ending 15 min after each paclitaxel dose. EORTC QLQ-CIPN20 was completed at baseline, weekly x12, then monthly x6. Area under the curve (AUC) was calculated for subscale scores, adjusting for baseline, and compared between arms (Wilcoxon rank-sum test). Cross-study comparisons used data from 2 prior similarly-conducted neuropathy trials. RESULTS Forty-six patients were accrued. Three withdrew and one was ineligible. Of the remaining 42 (21 cryotherapy, 21 control), 39 (19 cryotherapy, 20 control) were analyzable for AUC. Cryotherapy was well tolerated, but the AUC of the CIPN20 sensory scores over 12 weeks of paclitaxel was not found to differ between the study arms (mean difference 3.45, 95% CI -3.13 to 10.02, p = 0.26). However, the control arm of the current trial experienced less neuropathy than did the placebo arms of two previous similar trials. When our cryotherapy arm was compared to the combined control arms from all three trials, the cryotherapy arm had less neuropathy (Wilcoxon Rank-Sum p = 0.01). CONCLUSION While there was no difference in CIPN20 scores identified between the 2 study arms in the current phase II trial, further investigation is needed given that the control arm experienced less neuropathy than was expected.
Collapse
Affiliation(s)
- Kathryn J Ruddy
- Department of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
| | - Jennifer Le-Rademacher
- Department of Biostatistics, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA
| | - Mario E Lacouture
- Department of Dermatology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA
| | - Mary Wilkinson
- Inova Hematology Oncology, 8501 Arlington Blvd., Suite 340, Fairfax, VA, 22031, USA
| | - Adedayo A Onitilo
- Marshfield Clinic - Weston Center, 3501 Cranberry Blvd., Weston, WI, 54476, USA
| | - Amy C Vander Woude
- Cancer and Hematology Centers of Western Michigan, 145 Michigan St. NE, #3100, Grand Rapids, MI, 49503, USA
| | | | - Travis Dockter
- Department of Biostatistics, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA
| | - Angelina D Tan
- Department of Biostatistics, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA
| | - Andreas Beutler
- Department of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA
| | - Charles L Loprinzi
- Department of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA
| |
Collapse
|
4
|
Bai XH, Chen ZM, Ma LH, He Z, Li G. Prevention effect of low-temperature atomization inhalation for radiation induced oral mucositis in patients with head and neck cancer undergoing radiotherapy. Cancer Manag Res 2019; 11:4327-4333. [PMID: 31190997 PMCID: PMC6512953 DOI: 10.2147/cmar.s206921] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2019] [Accepted: 04/18/2019] [Indexed: 11/23/2022] Open
Abstract
Purpose: To investigate the prevention effect of low-temperature atomization inhalation for radiation induced oral mucositis (OM) in patients with head and neck cancer (HNC) undergoing radiotherapy. Patients and methods: A total of 68 patients with HNC (including nasopharyngeal cancer) undergoing radiotherapy were divided into an intervention group (33 cases) and a control group (35 cases). During radiotherapy, the intervention group received low-temperature (between 4°C and 8°C) atomization inhalation; while the control group received normal temperature (between 18°C and 24°C) atomization inhalation. Atomization inhalation was performed twice a day, 20 minutes per time, using distilled water. The incidence and severity of OM was evaluated every week during radiotherapy. The comparation was made between the two groups. Results: The two groups were comparable among age, sex, Eastern Cooperative Oncology group (ECOG) score, body mass index (BMI) before radiotherapy, BMI loss during radiotherapy, original tumor site, pathological type, TNM stage, and mean oral cavity irradiated dose. There was a significant difference in the incidence of OM between the two groups (P<0.05). There were fewer patients with severe OM in the intervention group compared to the control group (P<0.05). The onset time of OM in the intervention group was delayed by about 4 days compared to that in the control group (P<0.05). Low-temperature atomization inhalation helped to avoid radiotherapy interruption in the intervention group. No patient in the intervention group suffered any adverse reaction for low-temperature atomization inhalation treatment. Conclusions: Low-temperature atomization inhalation can reduce the incidence and severity of OM, and slow down the progression process of it. It can be used as a new prevention method during radiotherapy, and should be promoted in clinical practice.
Collapse
Affiliation(s)
- Xing-Hua Bai
- Department of Radiation Oncology, The First Affiliated Hospital of China Medical University, Shenyang, People’s Republic of China
| | - Zi-Min Chen
- Department of Radiation Oncology, The First Affiliated Hospital of China Medical University, Shenyang, People’s Republic of China
| | - Liang-Hua Ma
- Department of Radiation Oncology, The First Affiliated Hospital of China Medical University, Shenyang, People’s Republic of China
| | - Zheng He
- Department of Radiation Oncology, The First Affiliated Hospital of China Medical University, Shenyang, People’s Republic of China
| | - Guang Li
- Department of Radiation Oncology, The First Affiliated Hospital of China Medical University, Shenyang, People’s Republic of China
| |
Collapse
|